BreezeBio

United States · Biotech

Develops genetic medicines enabled by precise, non-viral nanoparticle delivery across tissues

Funding history

1 round · 1 with disclosed amounts
AnnouncedRoundAmountInvestors
Series B$60MACVC Partners — Role not disclosedDAYLI Partners — Role not disclosedDSC Investment — Role not disclosedKDB Silicon Valley — Role not disclosedKiwoom Investment — Role not disclosedKorea Investment Partners — Role not disclosedLoftyRock Investment — Role not disclosedPathway Investment — Role not disclosedSTIC Ventures — Role not disclosedSV Investment — Role not disclosedTop Harvest Capital — Role not disclosedWoori Venture Partners — Role not disclosedYuanta Investment — Role not disclosed
Sourcesbreezebio.com ↗